NCT02565381

Brief Summary

The QUIT (Quitting with Usual Care, Incentives, and Technology) Smoking Study is a 3-arm pilot randomized controlled trial that will test the effect of 2 different experimental smoking cessation interventions relative to a control condition in homeless cigarette smokers. All participants will receive free transdermal nicotine patches and weekly in-person smoking cessation counseling. In addition, participants randomized to the first experimental condition will receive financial rewards for biochemically-verified smoking abstinence, and participants randomized to the second experimental condition will be enrolled in a text messaging program to support smoking abstinence.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
83

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 1, 2015

Completed
Same day until next milestone

Study Start

First participant enrolled

October 1, 2015

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
12 months until next milestone

Results Posted

Study results publicly available

July 14, 2017

Completed
Last Updated

July 14, 2017

Status Verified

June 1, 2017

Enrollment Period

8 months

First QC Date

September 29, 2015

Results QC Date

May 20, 2017

Last Update Submit

June 15, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Biochemically-verified Smoking Abstinence, Assessed 14 Times Over 8 Weeks

    The primary outcome is a repeated-measures assessment of smoking abstinence, defined as an exhaled carbon monoxide \<8ppm and assessed 14 times over the 8-week study period (3 times/week for the first 2 weeks, 2 times/week for the next 2 weeks, and once every week for the last 4 weeks)

    Point-in-time abstinence assessed in a repeated fashion 14 times over the 8-week study period

Secondary Outcomes (7)

  • Percentage of Visits Abstinent of Smoking

    8 weeks

  • Smoking Abstinence at End of Study

    8 weeks

  • Change in Cigarette Consumption

    Once per week for 8 weeks

  • Change in Behavioral Health

    4 weeks and 8 weeks

  • Study Visit Attendance

    8 weeks

  • +2 more secondary outcomes

Other Outcomes (3)

  • Recruitment Time

    Until target number of participants is reached; anticipate ~6 months

  • Mobile Phone Retention

    8 weeks

  • Use of Text Messaging Program

    8 weeks

Study Arms (3)

Control (N=25)

ACTIVE COMPARATOR

* Transdermal nicotine patch * In-person smoking cessation counseling

Drug: Transdermal nicotine patchBehavioral: In-person smoking cessation counseling

Financial rewards (N=25)

EXPERIMENTAL

* Transdermal nicotine patch * In-person smoking cessation counseling * Contingent financial rewards for smoking abstinence

Drug: Transdermal nicotine patchBehavioral: In-person smoking cessation counselingBehavioral: Contingent financial rewards for smoking abstinence

Text messaging (N=25)

EXPERIMENTAL

* Transdermal nicotine patch * In-person smoking cessation counseling * Text messages to support smoking abstinence

Drug: Transdermal nicotine patchBehavioral: In-person smoking cessation counselingBehavioral: Text messages to support smoking abstinence

Interventions

* ≥10 cigarettes per day: nicotine 21mg/24hr patch daily x 6 weeks, then nicotine 14mg/24hr patch daily x 2 weeks * \<10 cigarettes per day: nicotine 14mg/24hr patch daily x 8 weeks

Also known as: Nicotine
Control (N=25)Financial rewards (N=25)Text messaging (N=25)

\- One-on-one 15-minute counseling sessions once per week for 8 weeks

Control (N=25)Financial rewards (N=25)Text messaging (N=25)

\- Escalating-value financial rewards for smoking abstinence, verified by exhaled carbon monoxide \<8ppm

Also known as: Contingency management
Financial rewards (N=25)

\- 1-5 text messages per day starting up to 2 weeks before the quit date and continuing until 6 weeks after the quit date, delivered by SmokefreeTXT

Text messaging (N=25)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Proficient in English, assessed with items asking about native language and self-reported comfort communicating in English among non-native speakers.
  • Age ≥18 years old, assessed by self-report and verified by date of birth.
  • Has smoked ≥100 cigarettes and currently smokes ≥5 cigarettes per day, verified by an exhaled carbon monoxide level of ≥8 ppm.
  • Ready to try quitting smoking within the next month.
  • Currently homeless, assessed by self-report and defined as usually staying in an emergency shelter, transitional shelter, abandoned building, place of business, car or other vehicle, church or mission, hotel or motel, or anywhere outside during the past 7 days. Additionally, individuals will be considered currently homeless if they usually stayed in somebody else's house, apartment/condominium, or room in the past 7 days because of not having their own place to stay.

You may not qualify if:

  • Currently pregnant, assessed by a urine pregnancy test conducted on all premenopausal biologic females who have not had a hysterectomy, or planning to become pregnant in the next 2 months.
  • Past 30-day use of nicotine replacement therapy, bupropion, or varenicline for smoking cessation, assessed by self-report. Use of bupropion for reasons other than to quit smoking (e.g. depression) is permissible.
  • Prior serious adverse reaction to the nicotine patch, defined as any reaction that was life-threatening or required hospitalization.
  • Heart attack or chest pain within the past 2 weeks.
  • Inability to read a sentence written at a Flesch-Kincaid grade level of 4.
  • Inability to provide informed consent, assessed with knowledge questions about the material presented during the informed consent process that individuals must correctly answer before providing informed consent to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Health Care for the Homeless Program

Boston, Massachusetts, 02118, United States

Location

Related Publications (3)

  • Baggett TP, McGlave C, Kruse GR, Yaqubi A, Chang Y, Rigotti NA. SmokefreeTXT for Homeless Smokers: Pilot Randomized Controlled Trial. JMIR Mhealth Uhealth. 2019 Jun 4;7(6):e13162. doi: 10.2196/13162.

  • Baggett TP, Yaqubi A, Berkowitz SA, Kalkhoran SM, McGlave C, Chang Y, Campbell EG, Rigotti NA. Subsistence difficulties are associated with more barriers to quitting and worse abstinence outcomes among homeless smokers: evidence from two studies in Boston, Massachusetts. BMC Public Health. 2018 Apr 10;18(1):463. doi: 10.1186/s12889-018-5375-z.

  • Baggett TP, Chang Y, Yaqubi A, McGlave C, Higgins ST, Rigotti NA. Financial Incentives for Smoking Abstinence in Homeless Smokers: A Pilot Randomized Controlled Trial. Nicotine Tob Res. 2018 Nov 15;20(12):1442-1450. doi: 10.1093/ntr/ntx178.

MeSH Terms

Conditions

Smoking

Interventions

Tobacco Use Cessation DevicesNicotine

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

TherapeuticsSolanaceous AlkaloidsAlkaloidsHeterocyclic CompoundsPyridinesHeterocyclic Compounds, 1-Ring

Limitations and Caveats

Small sample size; short duration of follow-up; primary outcome based exclusively on exhaled carbon monoxide measurement.

Results Point of Contact

Title
Travis P. Baggett, MD, MPH (Principal Investigator)
Organization
Massachusetts General Hospital

Study Officials

  • Travis P Baggett, MD, MPH

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Medicine

Study Record Dates

First Submitted

September 29, 2015

First Posted

October 1, 2015

Study Start

October 1, 2015

Primary Completion

June 1, 2016

Study Completion

August 1, 2016

Last Updated

July 14, 2017

Results First Posted

July 14, 2017

Record last verified: 2017-06

Locations